Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines (2017)
- Authors:
- USP affiliated authors: SCHEUCHER, PRISCILA SANTOS - FMRP ; REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- Subjects: LEUCEMIA; PROTEÍNAS; HEMATOPOESE
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2017
- Source:
- Título do periódico: Revista Brasileira de Hematologia e Hemoterapia
- ISSN: 1516-8484
- Volume/Número/Paginação/Ano: v. 39, suppl. 1, S125-S126, res. 344, 2017
- Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO 2017)
-
ABNT
PEREIRA-MARTINS, Diego A. et al. Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf. Acesso em: 23 abr. 2024. , 2017 -
APA
Pereira-Martins, D. A., Weinhauser, I., Almeida, L. Y. de, Scheucher, P. S., Wagatsuma, V. M. de D., Lucena-Araújo, A. R., & Rego, E. M. (2017). Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf -
NLM
Pereira-Martins DA, Weinhauser I, Almeida LY de, Scheucher PS, Wagatsuma VM de D, Lucena-Araújo AR, Rego EM. Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39[citado 2024 abr. 23 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf -
Vancouver
Pereira-Martins DA, Weinhauser I, Almeida LY de, Scheucher PS, Wagatsuma VM de D, Lucena-Araújo AR, Rego EM. Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39[citado 2024 abr. 23 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf - ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells
- Proliferação e morte celular programada na gênese da leucemia promielocítica aguda no modelo transgênico hCG-PML-RAR'alfa'
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
- Stathmin 1 é altamente expressa em leucemia promielocítica aguda e a dinâmica dos microtúbulos é um alvo potencial para células PML-RAR resistentes ao atra
- Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia
- CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice
- A inibição farmacológica de IRS1/2 induz apoptose em células BCR-ABL1 T315I
- Aplicação integrada de critérios clínicos, citogenéticos e moleculares na estratificação de risco em pacientes com leucemia mieloide aguda em laboratório de referência em um estudo multicêntrico brasileiro
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
